Altistavix
Altistavix is a synthetic cannabinoid receptor agonist, also known as a designer drug, that was first identified in the United States in 2014. It is a member of the indazole class of synthetic cannabinoids, which are designed to mimic the effects of the natural cannabinoids found in the cannabis plant. Altistavix is structurally similar to other synthetic cannabinoids such as AB-FUBINACA and AB-CHMINACA, but it has a unique chemical structure that sets it apart.
Altistavix is known to produce psychoactive effects similar to those of cannabis, including euphoria, altered perception,
The use of Altistavix has been associated with various health risks, including cardiovascular problems, psychosis, and
Altistavix is not approved for medical use and is not available over the counter. It is important